Correlation Between Virax Biolabs and Enliven Therapeutics
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Enliven Therapeutics, you can compare the effects of market volatilities on Virax Biolabs and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Enliven Therapeutics.
Diversification Opportunities for Virax Biolabs and Enliven Therapeutics
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Virax and Enliven is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Enliven Therapeutics go up and down completely randomly.
Pair Corralation between Virax Biolabs and Enliven Therapeutics
Given the investment horizon of 90 days Virax Biolabs Group is expected to under-perform the Enliven Therapeutics. In addition to that, Virax Biolabs is 2.04 times more volatile than Enliven Therapeutics. It trades about -0.09 of its total potential returns per unit of risk. Enliven Therapeutics is currently generating about -0.02 per unit of volatility. If you would invest 2,239 in Enliven Therapeutics on December 28, 2024 and sell it today you would lose (181.00) from holding Enliven Therapeutics or give up 8.08% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Virax Biolabs Group vs. Enliven Therapeutics
Performance |
Timeline |
Virax Biolabs Group |
Enliven Therapeutics |
Virax Biolabs and Enliven Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Virax Biolabs and Enliven Therapeutics
The main advantage of trading using opposite Virax Biolabs and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Cardio Diagnostics Holdings |
Enliven Therapeutics vs. Pmv Pharmaceuticals | Enliven Therapeutics vs. Cullinan Oncology LLC | Enliven Therapeutics vs. Immuneering Corp | Enliven Therapeutics vs. Aerovate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |